Alexander Seelenberger, MBA is the Chief Financial Officer of Vincerx. Mr Seelenberger has been a managing partner at Aurus Capital, a leading Latin American venture capital firm, heading its healthcare venture capital practice, since March 2009. In that role, Mr Seelenberger has co-founded and has been an executive director in several healthcare companies. From August 2007 to January 2009, Mr Seelenberger served as an associate at Athelera LLC, a New York-based boutique investment bank offering financial advisory services to clients in the United States, Latin America and Europe. Mr Seelenberger has served as a member of the board of directors of Andes Biotechnologies, a nucleic acid-based drug discovery and development company, since September 2009, Trigemina Holdings, Inc., a pharmaceutical company, since March 2012, Levita Magnetics, a magnetic surgical platform development company, since January 2012, Echopixel, Inc., a medical imaging device development company, since September 2012, and Algenis, a bioactive molecule development company, since December 2012.
Mr Seelenberger received a BBA in business from the University of Chile and an MBA with high distinction from Harvard Business School, where he graduated as a Baker Scholar.
What is Alexander A. Seelenberger's net worth?
The estimated net worth of Alexander A. Seelenberger is at least $25,738.00 as of August 11th, 2023. Mr. Seelenberger owns 30,280 shares of Vincerx Pharma stock worth more than $25,738 as of April 20th. This net worth evaluation does not reflect any other investments that Mr. Seelenberger may own. Additionally, Mr. Seelenberger receives an annual salary of $458,030.00 as CFO at Vincerx Pharma. Learn More about Alexander A. Seelenberger's net worth.
How old is Alexander A. Seelenberger?
Mr. Seelenberger is currently 45 years old. There are 3 older executives and no younger executives at Vincerx Pharma. The oldest executive at Vincerx Pharma is Mr. Tom C. Thomas J.D., Founder, General Counsel & Chief Legal Officer, who is 65 years old. Learn More on Alexander A. Seelenberger's age.
What is Alexander A. Seelenberger's salary?
As the CFO of Vincerx Pharma, Inc., Mr. Seelenberger earns $458,030.00 per year. There are 2 executives that earn more than Mr. Seelenberger. The highest earning executive at Vincerx Pharma is Dr. Ahmed M. Hamdy M.D., Founder, Chairman & CEO, who commands a salary of $609,840.00 per year. Learn More on Alexander A. Seelenberger's salary.
How do I contact Alexander A. Seelenberger?
Has Alexander A. Seelenberger been buying or selling shares of Vincerx Pharma?
Alexander A. Seelenberger has not been actively trading shares of Vincerx Pharma in the last ninety days. Most recently, on Friday, August 11th, Alexander A. Seelenberger bought 10,500 shares of Vincerx Pharma stock. The stock was acquired at an average cost of $0.95 per share, with a total value of $9,975.00. Following the completion of the transaction, the insider now directly owns 30,280 shares of the company's stock, valued at $28,766. Learn More on Alexander A. Seelenberger's trading history.
Who are Vincerx Pharma's active insiders?
Are insiders buying or selling shares of Vincerx Pharma?
During the last year, Vincerx Pharma insiders bought shares 2 times. They purchased a total of 27,400 shares worth more than $26,030.00. The most recent insider tranaction occured on August, 11th when insider Alexander A Seelenberger bought 10,500 shares worth more than $9,975.00. Insiders at Vincerx Pharma own 20.6% of the company.
Learn More about insider trades at Vincerx Pharma. Information on this page was last updated on 8/11/2023.
